Norinchukin Bank, The Abb Vie Inc. Transaction History

Norinchukin Bank, The

$4.18 Billion
Q3 2024

A detailed history of Norinchukin Bank, The transactions in Abb Vie Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 72,923 shares of ABBV stock, worth $12.8 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

72,923

Previous 62,576 16.54%

Holding current value

$12.8 Million

Previous $10.7 Million 34.17%

% of portfolio

0.34%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $1.7 Million - $2.06 Million	10,347 Added 16.54%	72,923 $14.4 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $111,139 - $129,785	718 Added 1.16%	62,576 $10.7 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $137,285 - $156,423	-859 Reduced 1.37%	61,858 $11.3 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $987,280 - $1.11 Million	-7,175 Reduced 10.27%	62,717 $9.72 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $9.34 Million - $10.8 Million	69,892 New	69,892 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $5.85 Million - $7.27 Million	44,115 Added 38.41%	158,972 $21.4 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $497,892 - $573,397	3,443 Added 3.09%	114,857 $18.3 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.79 Million - $4.55 Million	-27,437 Reduced 19.76%	111,414 $18 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.16 Million - $2.48 Million	16,104 Added 13.12%	138,851 $18.6 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $5.74 Million - $7.3 Million	-41,698 Reduced 25.36%	122,747 $18.8 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $1.69 Million - $2.1 Million	12,822 Added 8.46%	164,445 $26.7 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $92,067 - $116,492	-857 Reduced 0.56%	151,623 $20.5 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $674,256 - $765,382	6,337 Added 4.34%	152,480 $16.4 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $82,379 - $91,775	-783 Reduced 0.53%	146,143 $16.5 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $248,998 - $274,117	2,434 Added 1.68%	146,926 $15.9 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $351,338 - $474,344	-4,365 Reduced 2.93%	144,492 $15.5 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $148,538 - $174,335	1,729 Added 1.18%	148,857 $13 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $1.61 Million - $2.16 Million	21,954 Added 17.54%	147,128 $14.4 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $7.43 Million - $11.3 Million	-115,160 Reduced 47.92%	125,174 $9.54 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $1.28 Million - $1.6 Million	-17,741 Reduced 6.87%	240,334 $21.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $356,088 - $428,120	5,654 Added 2.24%	258,075 $19.5 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $6.8 Million - $8.69 Million	-103,433 Reduced 29.07%	252,421 $18.4 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $252,787 - $297,518	3,277 Added 0.93%	355,854 $28.7 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $6.27 Million - $7.73 Million	80,478 Added 29.58%	352,577 $32.5 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $2.02 Million - $2.25 Million	22,757 Added 9.13%	272,099 $25.7 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $1.91 Million - $2.26 Million	21,257 Added 9.32%	249,342 $23.1 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $1.78 Million - $2.38 Million	19,296 Added 9.24%	228,085 $21.6 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $1.42 Million - $1.56 Million	-15,837 Reduced 7.05%	208,789 $20.2 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $15.7 Million - $20 Million	224,626	224,626 $20 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Abb Vie Inc. Transaction History